Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity. 1997

K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
Division of Medicinal Chemistry, Codon Pharmaceuticals, Inc., Gaithersburg, Maryland 20877, USA.

Thiazole-4-carboxamide adenine dinucleotide (TAD) analogue 7 containing a fluorine atom at the C2' arabino configuration of the adenine nucleoside moiety was found to be a potent inducer of differentiation of K562 erythroid leukemia cells. This finding prompted us to synthesize its hydrolysis-resistant methylenebis(phosphonate) and difluoromethylenebis(phosphonate) analogues 8 and 9, respectively. Since both TAD and benzamide adenine dinucleotide (BAD) are potent inhibitors of inosine monophosphate dehydrogenase (IMPDH), the corresponding fluorine-substituted methylenebis(phosphonate) analogue 12 of BAD was also synthesized. Thus, 9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine (13) was converted in five steps into the corresponding methylenebis(phosphonate) analogue 18. Dehydration of 18 with DCC led to the formation of the bicyclic trisanhydride intermediate 19a, which upon reaction with 2',3'-O-isopropylidenetiazofurin (20) or -benzamide riboside (21) followed by hydrolysis and deprotection afforded the desired methylene-bridged dinucleotides 8 and 12, respectively. The similar displacement of the 5'-mesyl function of 2',3'-O-isopropylidene-5'-O-mesyltiazofurin (24) with the difluoromethylenebis(phosphonic acid) derivative gave the phosphonate 25 which was coupled with 13 to afford 26. The desired difluoromethylenebis(phosphonate) analogue 9 was obtained by deprotection with Dowex 50/H+. This compound as well as beta-CF2-TAD (4) showed improved differentiation-inducing activity over beta-CH2-TAD (3), whereas analogues containing the -CH2-linkage (8 and 12) were inactive.

UI MeSH Term Description Entries
D007168 IMP Dehydrogenase An enzyme that catalyzes the dehydrogenation of inosine 5'-phosphate to xanthosine 5'-phosphate in the presence of NAD. EC 1.1.1.205. Inosinic Acid Dehydrogenase,Inosine-5-Monophosphate Dehydrogenase,Acid Dehydrogenase, Inosinic,Dehydrogenase, IMP,Dehydrogenase, Inosine-5-Monophosphate,Dehydrogenase, Inosinic Acid,Inosine 5 Monophosphate Dehydrogenase
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005461 Fluorine A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries. Fluorine-19,Fluorine 19
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000227 Adenine Nucleotides Adenine Nucleotide,Adenosine Phosphate,Adenosine Phosphates,Nucleotide, Adenine,Nucleotides, Adenine,Phosphate, Adenosine,Phosphates, Adenosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites
D001549 Benzamides BENZOIC ACID amides.

Related Publications

K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
March 1995, Journal of medicinal chemistry,
K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
June 1996, Journal of medicinal chemistry,
K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
March 2005, Bioorganic & medicinal chemistry,
K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
June 1983, Journal of medicinal chemistry,
K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
September 1986, Journal of medicinal chemistry,
K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
August 2006, Journal of medicinal chemistry,
K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
August 2008, Bioorganic & medicinal chemistry,
K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
October 1993, Carbohydrate research,
K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
October 1989, Cancer research,
K Lesiak, and K A Watanabe, and A Majumdar, and M Seidman, and K Vanderveen, and B M Goldstein, and K W Pankiewicz
January 1990, Biochemistry,
Copied contents to your clipboard!